Patient Derived Xenograft/PDX Models Market by Type (Mouse & Rat), Tumor Type (Gastrointestinal, Gynecological, Respiratory), Application (Pre-Clinical Drug Development & Biomarker Analysis), End User (Pharma & Biotech, CRO)- Global Forecast to 2022

  • ID: 4395168
  • Report
  • Region: Global
  • 155 Pages
  • Markets and Markets
1 of 6
The Global PDX Models Market is Estimated to Grow at a CAGR of 16.7% from 2017 to 2022, to Reach USD 167.6 Million.

FEATURED COMPANIES

  • Champions Oncology, Inc.
  • Crown Bioscience Inc.
  • EPO Berlin-Buch GmbH
  • Hera Biolabs
  • ONCODESIGN
  • Pharmatest Services Ltd.
  • MORE

“PDX models market is projected to grow at a CAGR of 16.7%”

The key factors driving the growth of the overall PDX models market include the growing demand for personalized medicine, continuous support for cancer research from the public as well as private sectors, and growth in the number of R&D activities in the pharmaceutical industry. However, the high cost of personalized PDX models and stringent guidelines regarding the ethical use of animals in cancer research are expected to restrain the growth of this market during the forecast period.

“The respiratory tumor models segment is projected to grow at the highest CAGR during the forecast period”

Based on tumor type, the PDX models market is segmented into gastrointestinal tumor models, gynecological tumor models, respiratory tumor models, urological tumor models, hematological tumor models, and other tumor models such as head & neck cancer, sarcoma, and melanoma. During the forecast period, the respiratory tumor models segment is expected to register the highest CAGR. Growth in this segment is mainly driven by the increasing focus of market players on generating lung cancer PDX models, which could lead to a breakthrough in lung cancer treatment, as lung cancer is the leading cause of cancer-related deaths across the globe.

“Asia Pacific to witness the highest growth during the forecast period”

Asia Pacific is expected to grow at the highest CAGR in the global PDX models market during the forecast period of 2017-2022. Strong research expenditure and the well-structured CRO industry in China, growth in biomedical & medical research in Japan, rising pharmaceutical R&D expenditure in India, and rising translational and biomedical research in Singapore are expected to drive the market growth during the forecast period.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-55%, Tier 25%, and Tier 20%
  • By Designation - C-level-43%, Director Level-32%, Others-25%
  • By Region - North America-38%, Europe-23%, Asia-Pacific-29%, RoW-10%

The various players in the PDX models market include Crown Bioscience Inc. (US), WuXi AppTec (China), Champions Oncology, Inc. (US), The Jackson Laboratory (US), ONCODESIGN (France), Charles River Laboratories International, Inc. (US), EPO Berlin-Buch GmBH (Germany), Shanghai LIDE Biotech Co., Ltd. (China), Xentech (France), Horizon Discovery Group PLC (UK), Urolead (France), and Explora BioLabs (US).

Research Coverage:

The report analyzes the PDX models market and aims at estimating the market size and the future growth potential of this market based on various segments such as type, tumor type, application, end user, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product and service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a greater share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product and service portfolios offered by the top players in the global PDX models market
  • Service Enhancement/Innovation: Detailed insights on upcoming trends and service launches in the global PDX models market
  • Market Development: Comprehensive information about the lucrative emerging markets by type, tumor type, application, end user, and region
  • Market Diversification: Exhaustive information about new services or service enhancements, growing geographies, recent developments, and investments in the global PDX models market
  • Competitive Assessment: In-depth assessment of growth strategies, products, and services of leading players in the market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Champions Oncology, Inc.
  • Crown Bioscience Inc.
  • EPO Berlin-Buch GmbH
  • Hera Biolabs
  • ONCODESIGN
  • Pharmatest Services Ltd.
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Industry Insights
2.2.2.2 Key Data From Primary Sources
2.2.2.3 Key Insights From Primary Sources
2.3 Market Size Estimation Methodology
2.4 Market Forecast Methodology
2.5 Market Data Validation and Triangulation
2.6 Assumptions

3 Executive Summary

4 Premium Insights
4.1 PDX Models Market Overview
4.2 Regional Analysis: Global Patient Derived Xenograft Models Market, By End User
4.3 Global PDX Models Market, By Tumor Type, 2017 & 2022
4.4 Regional Snapshot of the Global Patient Derived Xenograft Models Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Demand for Personalized Medicine
5.2.1.2 Continuous Support for Cancer Research From Public as Well as Private Sector
5.2.1.3 Growth in the Number of Pharmaceutical R&D Activities
5.2.2 Restraints
5.2.2.1 High Cost of Personalized PDX Models
5.2.2.2 Stringent Guidelines for the Use of Animal Models in Cancer Research
5.2.3 Opportunity
5.2.3.1 Rising Demand for Humanized PDX Models
5.2.4 Challenge
5.2.4.1 Limitations of PDX Models

6 Patient Derived Xenograft Models Market, By Type
6.1 Introduction
6.2 Mice Models
6.3 Rat Models

7 Patient Derived Xenograft Models Market, By Tumor Type
7.1 Introduction
7.2 Gastrointestinal Tumor Models
7.3 Gynecological Tumor Models
7.4 Respiratory Tumor Models
7.5 Urological Tumor Models
7.6 Hematological Tumor Models
7.7 Other Tumor Models

8 Patient Derived Xenograft Models Market, By Application
8.1 Introduction
8.2 Preclinical Drug Development and Basic Cancer Research
8.3 Biomarker Analysis

9 Patient Derived Xenograft Models Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Contract Research Organizations
9.4 Academic & Research Institutions

10 Patient Derived Xenograft Models Market, By Region
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Growing Focus on Cancer Research in the US
10.2.1.2 Rise in Mab Production
10.2.1.3 Development of Oncology Biosimilars Boosting the Demand for Preclinical Services
10.2.2 Canada
10.2.2.1 Rising Stem Cell Research
10.3 Europe
10.3.1 Focus on Cancer Research and Treatment
10.3.2 Germany: Growth of the Biotech Sector
10.3.3 Spain: Availability of Venture Funding for Life Sciences
10.3.4 Italy: Growth of the Biotech, Pharma Sectors
10.3.5 Rising Research Investments in Sweden, Austria, and Denmark
10.4 Asia Pacific
10.4.1 Rising Focus on Precision Medicine and Personalized Medicine in China
10.4.2 Strong Research Expenditure and Well-Structured Cros Industry in China
10.4.3 Growing Focus of Pharmaceutical and Animal Research Model Suppliers on China
10.4.4 Public and Private Investments in China’s Life Sciences Sector
10.4.5 Initiatives to Reduce Long Approval Times in China
10.4.6 Intellectual Property (Ip) Breaches, A Challenge for Market Growth in China
10.4.7 Japan: Growth in Biomedical and Medical Research
10.4.8 India: Rising R&D Expenditure
10.4.9 Infrastructural Limitations in India
10.4.10 Availability of Funding for Biomedical Research in Australia
10.4.11 Rising Translational and Biomedical Research in SingAPOre
10.4.12 Rising Pharmaceutical and Biotechnology R&D in Korea
10.5 Rest of the World (RoW)
10.5.1 Rising R&D in Brazil
10.5.2 Growth of the Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE

11 Competitive Landscape
11.1 Introduction
11.2 Market Ranking Analysis
11.3 Competitive Leadership Mapping
11.3.1 Visionary Leaders
11.3.2 Innovators
11.3.3 Emerging Companies
11.3.4 Dynamic Differentiators
11.4 Competitive Benchmarking
11.4.1 Strength of Product Portfolio
11.4.2 Business Strategy Excellence

*Top 15 companies analyzed for this studies are - Crown Bioscience Inc. (US), Champions Oncology, Inc. (US), The Jackson Laboratory (US), Charles River Laboratories, International, Inc. (US), WuXi AppTec (China), ONCODESIGN (France), EPO Berlin-Buch GmbH   (Germany), Shanghai LIDE Biotech Co., Ltd. (China), Xentech (France), Horizon Discovery Group PLC (UK), Pharmatest Services Ltd. (Finland), Hera BioLabs (US), Urolead (France), Xenopat (Spain), Bioduro (US)

12 Company Profiles
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
12.1 Crown Bioscience Inc.
12.2 the Jackson Laboratory
12.3 Champions Oncology, Inc.
12.4 Charles River Laboratories International, Inc.
12.5 WuXi Apptec (Group of Subsidiaries Under WuXi Pharmatec)
12.6 ONCODESIGN
12.7 Horizon Discovery Group PLC  (Sage Labs, Inc.)
12.8 Pharmatest Services Ltd.
12.9 Hera Biolabs
12.10 EPO Berlin-Buch GmbH
12.11 Xentech
12.12 Urolead
*Details on View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix
13.1 Discussion Guide
13.2 Knowledge Store: Subscription Portal
13.3 Introducing RT: Real-Time Market Intelligence
13.4 Available Customizations
13.5 Related Reports
13.6 Author Details

List of Tables
Table 1 Global PDX Models Market, By Type, 2015-2022 (USD Million)
Table 2 PDX Mice Models Market, By Region, 2015-2022 (USD Million)
Table 3 PDX Rat Models Market, By Region, 2015-2022 (USD Thousand)
Table 4 Global Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Million)
Table 5 Gastrointestinal Tumor Models Market, By Region, 2015-2022 (USD Million)
Table 6 Gynecological Tumor Models Market, By Region, 2015-2022 (USD Million)
Table 7 Respiratory Tumor Models Market, By Region, 2015-2022 (USD Million)
Table 8 Urological Tumor Models Market, By Region, 2015-2022 (USD Thousand)
Table 9 Hematological Tumor Models Market, By Region, 2015-2022 (USD Thousand)
Table 10 Other Tumor Models Market, By Region, 2015-2022 (USD Million)
Table 11 Global PDX Models Market, By Application, 2015-2022 (USD Million)
Table 12 Patient Derived Xenograft Models Market for Preclinical Drug Development and Basic Cancer Research, By Region, 2015-2022 (USD Million)
Table 13 PDX Models Market for Biomarker Analysis, By Region, 2015-2022 (USD Million)
Table 14 Global Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)
Table 15 PDX Models Market for Pharmaceutical & Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 16 PDX Models Market for Contract Research Organizations,  By Region, 2015-2022 (USD Million)
Table 17 Patient Derived Xenograft Models Market for Academic & Research Institutions, By Region, 2015-2022 (USD Million)
Table 18 Global Market, By Region, 2015-2022 (USD Million)
Table 19 North America: PDX Models Market, By Country, 2015-2022 (USD Million)
Table 20 North America: Patient Derived Xenograft Models Market, By Type, 2015-2022 (USD Million)
Table 21 North America: Market, By Tumor Type, 2015-2022 (USD Million)
Table 22 North America: Market, By Application, 2015-2022 (USD Million)
Table 23 North America: Market, By End User, 2015-2022 (USD Million)
Table 24 US: PDX Models Market, By Type, 2015-2022 (USD Million)
Table 25 US: Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Million)
Table 26 US: PDX Models Market, By Application, 2015-2022 (USD Million)
Table 27 US: Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)
Table 28 Canada: PDX Models Market, By Type, 2015-2022 (USD Million)
Table 29 Canada: Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Million)
Table 30 Canada: PDX Models Market, By Application, 2015-2022 (USD Million)
Table 31 Canada: Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)
Table 32 Europe: PDX Models Market, By Type, 2015-2022 (USD Million)
Table 33 Europe: Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Million)
Table 34 Europe: PDX Models Market, By Application, 2015-2022 (USD Million)
Table 35 Europe: Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)
Table 36 Japan: Significant Partnerships
Table 37 Asia Pacific: PDX Models Market, By Type, 2015-2022 (USD Million)
Table 38 Asia Pacific: Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Million)
Table 39 Asia Pacific: PDX Models Market, By Application, 2015-2022 (USD Million)
Table 40 Asia Pacific: Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)
Table 41 RoW: PDX Models Market, By Type, 2015-2022 (USD Thousand)
Table 42 RoW: Patient Derived Xenograft Models Market, By Tumor Type, 2015-2022 (USD Thousand)
Table 43 RoW: PDX Models Market, By Application, 2015-2022 (USD Million)
Table 44 RoW: Patient Derived Xenograft Models Market, By End User, 2015-2022 (USD Million)

List of Figures
Figure 1 Global PDX Models Market: Research Methodology Steps
Figure 2 Sampling Frame: Primary Research
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Estimation Methodology: Bottom-Up Approach
Figure 5 Market Size Estimation Methodology: Top-Down Approach
Figure 6 Market Forecast Methodology
Figure 7 Data Triangulation Methodology
Figure 8 Global PDX Models Market, By Type (2017)
Figure 9 Global Patient Derived Xenograft Models Market, By Tumor Type (2017)
Figure 10 Global PDX Models Market, By Application
Figure 11 Global Patient Derived Xenograft Models Market, By End User
Figure 12 Asia Pacific to Witness Highest Growth During the Forecast Period
Figure 13 Growing Cancer Research to Drive the Global PDX Models Market
Figure 14 North America is Expected to Dominate the Patient Derived Xenograft Models Market in 2017
Figure 15 Gastrointestinal Tumors to Account for the Largest Share of the Market in 2017
Figure 16 The Asia Pacific Region to Grow at the Highest CAGR During the Forecast Period
Figure 17 PDX Models Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Mice Models to Dominate the Patient Derived Xenograft Models Market During the Forecast Period
Figure 19 Gastrointestinal Tumor Models is Expected to Account for the Largest Market Share in 2017
Figure 20 Preclinical Drug Development and Basic Cancer Research Applications to Dominate the PDX Models Market
Figure 21 Contract Research Organizations to Register the Highest CAGR During the Forecast Period
Figure 22 Asia Pacific to Grow at the Highest CAGR in the Patient Derived Xenograft Models Market
Figure 23 North America: PDX Models Market Snapshot
Figure 24 Europe: Patient Derived Xenograft Models Market Snapshot
Figure 25 Asia Pacific: PDX Models Market Snapshot
Figure 26 RoW: Patient Derived Xenograft Models Market Snapshot
Figure 27 Global PDX Model Market Ranking (As of 2016)
Figure 28 PDX Models Market (Global) Competitive Leadership Mapping,2017
Figure 29 The Jackson Laboratory: Company Snapshot (2016)
Figure 30 Champions Oncology, Inc.: Company Snapshot (2016)
Figure 31 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 32 WuXi Pharmatec: Company Snapshot (2015)
Figure 33 ONCODESIGN: Company Snapshot (2016)
Figure 34 Horizon Discovery Group PLC: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Champions Oncology, Inc.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience Inc.
  • EPO Berlin-Buch GmbH
  • Hera Biolabs
  • Horizon Discovery Group PLC  (Sage Labs, Inc.)
  • ONCODESIGN
  • Pharmatest Services Ltd.
  • The Jackson Laboratory
  • Urolead
  • WuXi Apptec (Group of Subsidiaries Under WuXi Pharmatec)
  • Xentech
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll